Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,576–6,600 of 7,816 matching trials · page 264 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease NCT01969123 Drug: EVP-6124; Placebo Runs in: Australia; Belgium; Canada; France; Germany; Italy; Mexic... · 82 sites |
PHASE3 other |
TERMINATED | 474 | FORUM Pharmaceuticals Inc INDUSTRY |
2016-05-03 |
|
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease NCT01969136 Drug: EVP-6124; Placebo Runs in: Argentina; Australia; Canada; Czechia; France; Germany; I... · 81 sites |
PHASE3 other |
TERMINATED | 403 | FORUM Pharmaceuticals Inc INDUSTRY |
2016-05-03 |
|
Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025 NCT02004392 EVP-6124 Runs in: Australia; Belgium; Canada; Czechia; Italy; Netherlands; ... · 86 sites |
PHASE3 other |
TERMINATED | 348 | FORUM Pharmaceuticals Inc INDUSTRY |
2016-05-03 |
|
Symptomatic Treatment of Vascular Cognitive Impairment NCT02098824 Galantamine; Methylphenidate; Placebo Runs in: Netherlands · 1 site |
PHASE2|PHASE3 symptomatic-cholinergic |
UNKNOWN | 30 | Amsterdam UMC, location VUmc OTHER |
2016-05-02 |
|
Calligraphy Writing for Cognitive and Emotional Enhancement Among Older MCI People NCT02755792 Calligraphy Training; iPad Training Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 99 | The Hong Kong Polytechnic University OTHER |
2016-04-29 |
|
Theoretical Based Case Management Intervention for Dementia Family Caregivers NCT02747745 Four risk areas reflecting the great needs of FCGs of PWDs Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 152 | Chang Gung University OTHER |
2016-04-22 |
|
Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART) NCT01688128 Phase I U-SMART (4 wks); Washout (2 wks); Phase II U-SMART (4 wks) Runs in: South Korea · 1 site |
PHASE3 other |
COMPLETED | 50 | Seoul National University Bundang Hospital OTHER |
2016-04-20 |
|
Effect of AQW051 in Patients With Memory Impairment NCT00582855 AQW051; Placebo Runs in: Canada; South Africa; United Kingdom · 12 sites |
PHASE2 other |
TERMINATED | 54 | Novartis Pharmaceuticals INDUSTRY |
2016-04-19 |
|
A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults NCT01732653 TT+VR; TT alone Runs in: Belgium; Israel; Italy; Netherlands; United Kingdom · 5 sites |
NA other |
COMPLETED | 302 | Tel-Aviv Sourasky Medical Center OTHER_GOV |
2016-04-19 |
|
Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease NCT01538212 |
NA other |
COMPLETED | 55 | Cerecin INDUSTRY |
2016-04-18 |
|
Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease NCT01715350 PM012; Placebo Runs in: South Korea · 4 sites |
PHASE2 other |
COMPLETED | 151 | VTBIO Co. LTD INDUSTRY |
2016-04-18 |
|
Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy NCT02238652 Communication; Systematic Pain Assessment and Treatment; Medication... Runs in: Norway · 32 sites |
NA other |
COMPLETED | 560 | University of Bergen OTHER |
2016-04-15 |
|
Honolulu Heart Program NCT00005123 |
NA other |
COMPLETED | — | National Heart, Lung, and Blood Institute (NHLBI) NIH |
2016-04-14 |
|
e-CHAMP: Enhancing Care for Hospitalized Older Adults With Memory Problems NCT00182832 e-CHAMP (Enhancing Care for Hospitalized Older Adults with Cognitiv... Runs in: United States · 1 site |
NA other |
COMPLETED | 424 | Indiana University OTHER |
2016-04-13 |
|
A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease NCT01944436 Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine) Runs in: Canada · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 57 | Sunnybrook Health Sciences Centre OTHER |
2016-04-13 |
|
Randomized Trial of Parent Training for Young Children With Autism NCT01233414 Parent Training; Psychoeducational Program Runs in: United States · 6 sites |
NA other |
COMPLETED | 180 | Yale University OTHER |
2016-04-08 |
|
Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China NCT01340950 zidovudine-lamivudine-nevirapine; tenofovir-lamivudine-efavirenz Runs in: China · 2 sites |
PHASE4 other |
COMPLETED | 250 | University of California, San Diego OTHER |
2016-04-04 |
|
A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease NCT00960531 ACC-001+ QS21 (3mcg); ACC-001 (10 mcg) + QS-21; ACC-001+QS-21 (30mcg) Runs in: United States · 28 sites |
PHASE2 other |
TERMINATED | 160 | Pfizer INDUSTRY |
2016-04-01 |
|
Effect of NeuroAD on the Cognitive Function of Alzheimer Patients NCT01825330 TMS and cognitive stimulation; sham Runs in: Israel; United States · 10 sites |
NA other |
COMPLETED | 131 | Neuronix Ltd INDUSTRY |
2016-03-31 |
|
Coenzyme Q10 in Huntington's Disease (HD) NCT00608881 coenzyme Q10; placebo Runs in: Australia; Canada; United States · 49 sites |
PHASE3 other |
TERMINATED | 609 | Massachusetts General Hospital OTHER |
2016-03-30 |
|
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease NCT01680588 [18F]NAV4694 Runs in: United States · 7 sites |
PHASE2 other |
UNKNOWN | 70 | Navidea Biopharmaceuticals INDUSTRY |
2016-03-30 |
|
Train the Brain - Cognitive and Physical Training for Slowing Dementia NCT01725178 Cognitive and Physical training Runs in: Italy · 1 site |
NA other |
UNKNOWN | 160 | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy OTHER_GOV |
2016-03-30 |
|
Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease? NCT01695889 Runs in: Sweden · 1 site |
NA other |
UNKNOWN | 877 | University Hospital, Linkoeping OTHER |
2016-03-25 |
|
Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory NCT00471107 DC brain polarization Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 45 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2016-03-24 |
|
Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL) NCT00880555 Runs in: United States · 1 site |
NA other |
COMPLETED | 78 | VA Office of Research and Development OTHER_GOV |
2016-03-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial